Abstract
Hepatopancreas of king crab Paralithodes camtschatica produces a metalloprotease, which belongs to the astacin family, as cDNA cloning and sequencing showed. The metalloprotease has been purified chromatographically to apparent homogeneity. The purification factor was 16 and activity recovery was 20%. pH and temperature optimum have been determined. In its properties (molecular weight, pI, metal content) the metalloprotease is close to crayfish astacin. However, analysis of the enzyme sequences revealed differences, which account for differences in substrate specificities and imply a different activation mechanism.
Keywords: Metalloprotease, astacin family, affinity chromatography, Paralithodes camtschatica
Protein & Peptide Letters
Title: cDNA Cloning, Purification and Properties of Paralithodes camtschatica Metalloprotease
Volume: 13 Issue: 6
Author(s): Svetlana A. Semenova, Galina N. Rudenskaya, Denis V. Rebrikov and Vyacheslav A. Isaev
Affiliation:
Keywords: Metalloprotease, astacin family, affinity chromatography, Paralithodes camtschatica
Abstract: Hepatopancreas of king crab Paralithodes camtschatica produces a metalloprotease, which belongs to the astacin family, as cDNA cloning and sequencing showed. The metalloprotease has been purified chromatographically to apparent homogeneity. The purification factor was 16 and activity recovery was 20%. pH and temperature optimum have been determined. In its properties (molecular weight, pI, metal content) the metalloprotease is close to crayfish astacin. However, analysis of the enzyme sequences revealed differences, which account for differences in substrate specificities and imply a different activation mechanism.
Export Options
About this article
Cite this article as:
Semenova A. Svetlana, Rudenskaya N. Galina, Rebrikov V. Denis and Isaev A. Vyacheslav, cDNA Cloning, Purification and Properties of Paralithodes camtschatica Metalloprotease, Protein & Peptide Letters 2006; 13 (6) . https://dx.doi.org/10.2174/092986606777145887
DOI https://dx.doi.org/10.2174/092986606777145887 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aspartic Proteases of Human Pathogenic Fungi are Prospective Targets for the Generation of Novel and Effective Antifungal Inhibitors
Current Enzyme Inhibition The PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast Cancer
Current Pharmaceutical Biotechnology Endothelial Dysfunction in Renal Failure: Current Update
Current Medicinal Chemistry Current Status of the Non-nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1
Current Topics in Medicinal Chemistry Treating Hypertension in the Elderly: Common Problems and Solutions
Current Hypertension Reviews Mitochondria as a Target for Exercise-Induced Cardioprotection
Current Drug Targets Drug Delivery Systems for the Treatment of Diabetes Mellitus: State of the Art
Current Pharmaceutical Design A Review of Sodium Glucose Co-transporter 2 Inhibitors Canagliflozin, Dapagliflozin and Empagliflozin
Cardiovascular & Hematological Agents in Medicinal Chemistry Benefits of Chinese Medicine Among Patients with Diabetic Foot: An Expert Review from Clinical Studies
Current Vascular Pharmacology The Impact of Infection on the Incidence of Autoimmune Disease
Current Topics in Medicinal Chemistry Is Metabolic Syndrome X a Disorder of the Brain?
Current Nutrition & Food Science Predicted Fold for the Abri Amyloid Subunit: A Model for Amyloidogenesis in Familial British Dementia
Protein & Peptide Letters Treatment Modalities for Hepatocellular Carcinoma
Current Cancer Drug Targets The Impact of Asymmetric Dimethylarginine (ADAMA), the Endogenous Nitric Oxide (NO) Synthase Inhibitor, to the Pathogenesis of Gastric Mucosal Damage
Current Pharmaceutical Design Design and Development of Preservative Free Herbal Dosage Forms
The Natural Products Journal Stimuli-Responsive Nanocarriers for Drug Delivery to the Central Nervous System
Current Nanoscience PI-3-Kinase Inhibitors in Colorectal Cancer
Current Cancer Drug Targets Bioactive Proteins and Peptides from Soybeans
Recent Patents on Food, Nutrition & Agriculture HPA Axis Function During the Perinatal Period in Patients with Affective Disorders
Current Psychiatry Reviews Peptido-Targeting of the Mitochondrial Transition Pore Complex for Therapeutic Apoptosis Induction
Current Pharmaceutical Design